All posts by David Emerson
INeligible ASCT Myeloma Patients-Longer PFS but Lower QOL
adding… daratumumab to standard therapy significantly extended progression-free survival (PFS) in patients newly diagnosed with multiple myeloma who were ineligible for stem cell transplant It is
Continue readingDysplasia of the Tongue-Reduce Risk of Cancer?
“Dysplasia is the step preceding the formation of squamous cell carcinoma in lesions which have the potential to undergo dysplasia.” Dear Cancer Coach-I was diagnosed with dysplasia of the
Continue readingLong-Term Myeloma Survivor Desperate for Cardio-Oncology
Cardio-oncology is a multidisciplinary specialty aimed at managing and preventing cardiovascular disease in cancer patients and survivors. With the changing landscape of cancer therapeutics, patients are
Continue reading$ Taints Oncology Research- Always Has, Always Will-
“They (oncologists) really are falsifying the information that others (cancer patients like me) rely on to assess that research,” Evidence-based research is the cornerstone of oncology. Study after
Continue readingSlow Cognitive Decline w/ B complex + Omega 3-
“A randomized trial (VITACOG) in people with mild cognitive impairment (MCI) found that B vitamin treatment to lower homocysteine slowed the rate of cognitive and clinical decline.” I am a
Continue readingMultiple Myeloma Patients are ALL “Toxicity-Vulnerable”
Are you a “Toxicity-Vulnerable” Multiple Myeloma Patient?” It isn’t just old people who are “vulnerable to chemotherapy toxicity.” Everyone suffers collateral damage
Continue readingRenal Cell Carcinoma Stage 4- Alpha Lipoic Acid/Low-dose Naltrexone
The patient had stable disease with disappearance of the signs and symptoms of stage IV RCC, a full 9 years following diagnosis Hi David-I have Renal Cell Carcinoma stage 4. I have need studying the ALA
Continue readingSevere Neutropenia a Plus in Pancreatic Cancer???
investigators concluded that there was an undeniable relationship between survival and the incidence of severe neutropenia in patients with pancreatic cancer treated with modified FOLFIRINOX Neutropenia (NEU) is
Continue readingMitigate Long-Term Cisplatin Damage in Testicular Cancer
“During that lifetime, they (testicular cancer survivors) are at increased risk of acute and late effects of testicular cancer and its therapies.” With survival rates topping 95%, there is
Continue readingRILP Minimized by Roam’s Elevate Exoskeleton?
So far most exoskeletons have conjured images of Iron Man, super soldiers or epic robot battles, but Elevate is for skiers that want a little extra boost or support while carving lines this season. I
Continue reading